Get started

Novo Nordisk A/S

No trades
See on Supercharts
Overview
News Ideas Financials Technicals Forecast

NVO chart

Key stats

Market capitalization
454.263BUSD
Dividends yield (FY)
0.72%
Price to earnings Ratio (TTM)
24.85
Basic EPS (TTM)
2.41USD
Net income
7.844BUSD
Revenue
24.998BUSD
Shares float
3.387B
Beta
0.48

About Novo Nordisk A/S

Sector
Health Technology
CEO
Lars Fruergaard Jørgensen
Headquarters
Bagsværd
Website
novonordisk.com
Employees (FY)
54.393K
Founded
1931
ISIN
US6701002056
Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

Ideas

VCP Breakout Buy in NVONovo Nordisk is emerging from a textbook volatility compression pattern (VCP) - the setup made famous by Mark Minervini. Notice the series of progressively shallower pullbacks from left to right as supply has been absorbed by buyers. NVO is a market-leading stock by all accounts. Shares are up 75%
Long
by rossgivens
NVO Novo Nordisk: $195 | The Cure since forever it addresses on major conditions of humans Diabetes Cardio Alzheimer's from acquisition to partnering and continuous r&d this issue is a model to new science and tech companies making it to the next 50 years key is innovation opportunity is wait for major crash to upsize for OG investors or s
by senyor
How long can Novo keep raising for? answer is in the videoThrough the application of the Wave analysis (Hurst, Gann, Swing trading etc) investors can be aware what to expect over the short and mid term. From 16.11 be aware that a retracement might happened. Intensity has to be monitored to understand the type of wave in development (Ti, T+2i or T+3i).
by TRADOMICA
NVO continues slow grind upwardNVO seemingly cannot be stopped and continues the uptrend, I tried to show this in a variety of wars. I added a local demand for another supportive region. The teal support is from september 2022, we are either going to dip into demand and consolidate nearby or jump to 106 in the coming week or two.
Long
by Apollo_CB
NVO climbs back to supportNVO is consolidating above the dashed green line which is good news for the bulls. New all time highs are on the horizon. Many have a hard time buying into 52 week highs, but the best compounders spend a lot of their time in this range, that is the nature of successful stocks and companies. I added
Long
by Apollo_CB
Novo Nordisk (NYSE: NVO): Trading Idea for 13/10/2023Pharmaceutical company Novo Nordisk completed its research into the treatment of kidney disease a year ahead of schedule. However, the results will only be published in early 2024. If the company demonstrates convincing positive results, Novo Nordisk's revenue growth prospects will be strong. Today
by RoboMarkets
Novo Nordisk In-depth analysis Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease. The Diabetes and Obesity care segment provides products in the areas of insulins, G
by SerpentForexClub
NVO short positionhi Traders We can see that NVO is in a bullish trend. It has been forming a rising wedge pattern . We expect the price to break down from the pattern. Our estimated target is 180.46 . Take short position at the breakout point if we get a volume increase.
Short
by vf_investment
1

See all ideas 

News Flow

Keep readingKeep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Financials

Performance
Revenue to profit conversion
Earnings
‪0‬

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
TradeStation
TradeStation
Featured
Stocks, Crypto, Futures
4.4Very Good
Learn more
Interactive Brokers
Interactive Brokers
Stocks, Futures, Bonds
4.4Very Good
Learn more

See all brokers 

Sparks

Curated watchlists where NVO is featured.

See all sparks